Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Study on drug interactions

K Venkatesan, V P Bharadwaj, G Ramu

    Leprosy in India
    |April 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Leprosy drug interactions were studied. Clofazimine with isoniazid lowered skin clofazimine levels but increased plasma and urine levels. Rifampicin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic diversity and camphor profiling of <i>Curcuma caesia</i> roxb.: identification of elite genotypes and in silico prediction of gastroprotective mechanisms.

    Frontiers in pharmacology·2026
    Same author

    Signal and Supply: Phytohormonal networks regulating source sink dynamics and assimilate partitioning.

    Plant science : an international journal of experimental plant biology·2026
    Same author

    Evaluation of Phytochemical Variations Among the Different Genotypes of Black Turmeric (Curcuma caesia Roxb.).

    Biochemical genetics·2025
    Same author

    Molecular characterization of curry leaf genotypes using ISSR markers.

    Scientific reports·2025
    Same author

    Nanostructured TiO<sub>2</sub> Surface Enriched with CeO<sub>2</sub> over Ti Metal for Enhanced Cytocompatibility and Osseointegration for Biomedical Applications.

    ACS applied materials & interfaces·2025
    Same author

    Synergistic effects of calcium and zinc on bio-functionalized 3D Ti cancellous bone scaffold with enhanced osseointegration capacity in rabbit model.

    Biomaterials advances·2024
    Same journal

    Toxic epidermal necrolysis (Lyell syndrome)

    Leprosy in India·1983
    Same journal

    'Frustration--anxiety behaviour as a function of leprosy patients age and personality'.

    Leprosy in India·1983
    Same journal

    Study of lymph node biopsies in lepromatous leprosy patients under treatment.

    Leprosy in India·1983
    Same journal

    Clinico-pathological study of lymph node involvement in leprosy.

    Leprosy in India·1983
    Same journal

    Short course treatment of tuberculoid cases--a feasibility study.

    Leprosy in India·1983
    Same journal

    The effect of clofazimine on liver function tests in lepra reaction (ENL).

    Leprosy in India·1983
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Drug Interactions

    Background:

    • Leprosy treatment relies on multidrug therapy (MDT).
    • Understanding drug interactions is crucial for optimizing leprosy treatment efficacy and safety.
    • Previous research has indicated potential pharmacokinetic variations with combined drug regimens.

    Purpose of the Study:

    • To investigate the pharmacokinetic interactions between key drugs used in leprosy combination therapy.
    • To assess the impact of isoniazid on clofazimine levels.
    • To evaluate the effect of clofazimine on dapsone excretion and rifampicin's effect on dapsone levels in different acetylator phenotypes.

    Main Methods:

    • In vivo studies were conducted to measure drug levels in plasma, urine, and skin.

    Related Experiment Videos

  • Specific drug combinations included isoniazid with clofazimine, and clofazimine with dapsone.
  • Plasma dapsone levels were analyzed in relation to rifampicin administration in both fast and slow acetylators.

    • Main Results:

    • Isoniazid supplementation with clofazimine therapy resulted in decreased skin clofazimine levels.
    • Concurrently, plasma and urinary clofazimine content increased when co-administered with isoniazid.
    • Concurrent administration of clofazimine with dapsone (DDS) did not significantly alter DDS excretion.
    • The plasma dapsone-lowering effect of rifampicin remained consistent across both fast and slow dapsone acetylators.

    Conclusions:

    • Isoniazid influences clofazimine pharmacokinetics, increasing systemic exposure while reducing skin deposition.
    • Clofazimine does not appear to affect dapsone excretion.
    • Rifampicin's effect on dapsone levels is independent of the patient's acetylator status, suggesting consistent efficacy in combination therapy.